Cedazuridine

Chemical Information
Myelodysplastic syndromes (MDS) are a group of hematopoietic neoplasms that give rise to variable cytopenias progressing to secondary acute myeloid leukemia (sAML), which is invariably fatal if untreated. Hypomethylating agents such as [decitabine] and [azacitidine] are used to treat MDS through inducing DNA hypomethylation and apoptosis of cancerous cells. Although effective, these compounds are rapidly metabolized by cytidine deaminase (CDA) prior to reaching systemic circulation when administered orally, necessitating intramuscular or intravenous administration routes. Cedazuridine is a fluorinated tetrahydrouridine derivative specifically designed to inhibit CDA and facilitate oral administration of hypomethylating agents. Cedazuridine was first reported in 2014, and was subsequently approved by the FDA on July 7, 2020, in combination with [decitabine] for sale by Astex Pharmaceuticals Inc under the name INQOVI®.
| CAS Number | 1141397-80-9 |
| PubChem CID | 25267009 |
| IUPAC Name | (4R)-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-hydroxy-1,3-diazinan-2-one |
| Molecular Formula | C9H14F2N2O5 |
| Molecular Weight | 268.21 |
| XLogP | -1.1 |
| Topological Polar Surface Area | 102 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Property | Value |
|---|---|
| Molecular Weight | 268.21 |
| XLogP3 | -1.1 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 2 |
| Exact Mass | 268.08707788 |
| Monoisotopic Mass | 268.08707788 |
| Topological Polar Surface Area | 102 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 343 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
Alternative Products
Popular Products

SequaGel MD SSCP Kit (Haz Fee)
SKU: EC-846|Size: 1 Kit

mPEG-SC, 1K
SKU: MF001023-1K-01|Size: 1 g

RABBIT, ANTI GOAT IGG, FC FRAGMENT, F (AB') 2
SKU: 9450212-0.5ML|Size: 1 Unit

BioCoupler® Glass Set (16 oz) x6
SKU: BCS166|Size: 6 Each

BioCoupler® x 1
SKU: BC1|Size: 1 Each

BioCoupler® x 6
SKU: BC6|Size: 6 Each

Histo-Quill Ultrafine Tip Pen for Casettes and Slides
SKU: H-QPen|Size: 12 / Pack

hTERT (CMV, Puro) lentivirus
SKU: LVP1130-Puro|Size: 1 x 10^7 IFU/mL - 200 µL

Goat anti-Human IgG Fc, min, cross-reactivity to bovine, horse, mouse or rabbit serum proteins or mouse IgG1
SKU: AS16 3346|Size: 1 mg

Dressed Gold® Goat anti-Human IgG (H+L) at 15 O.D./mL, 1 mL
SKU: DGHG-B001|Size: 1 mL

SmartPAGETM Precast Protein Gel Plus 15 Wells
SKU: SLE022|Size: 10%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 15 Wells
SKU: SLE023|Size: 12%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 12 Wells
SKU: SLE014|Size: 4-12%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 12 Wells
SKU: SLE015|Size: 4-20%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 12 Wells
SKU: SLE016|Size: 8%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 12 Wells
SKU: SLE017|Size: 10%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 12 Wells
SKU: SLE018|Size: 12%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 15 Wells
SKU: SLE019|Size: 4-12%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 15 Wells
SKU: SLE020|Size: 4-20%, Bis-Tris

SmartPAGETM Precast Protein Gel Plus 15 Wells
SKU: SLE021|Size: 8%, Bis-Tris
